Hello Inside, an organization that focuses on enhancing metabolic well-being via small wearable continuous glucose monitoring (CGM), has raised €1.65 million in a more recent funding round. Such investment, spearheaded by well-known European funders, shows that enhancing an individualized approach to women’s health became a priority.
Image Source: Hello Inside
Funding Environment
Funding has remained a significant hurdle for health tech startups with investors limiting their support. However, through these challenges, Hello Inside has proven to be capable of securing €1.65 million underlines the confidence of the investors in its effectiveness on the given approach and its ability to make a difference. This funding will help Hello Inside to grow its app and reach more women interested in getting healthier metabolisms.
Mission and Vision of Hello Inside
Hello Inside was founded with a clear mission to enable women to take a proactive stand towards their macronutrient requirements by arming them with all the information they require. It is by using CGM technology that the company provides the user with real-time data regarding his or her blood glucose level which decisions regarding diet, exercise, and lifestyle can be made.
The company’s vision is to revolutionize the way women manage their health through easy and grounded metabolic information. To elaborate, Hello Inside simply targets women’s specific health concerns, including weight loss goals, fatigue, and their constantly changing hormones.
Continuous Glucose Monitoring (CGM)
Continuous glucose monitoring (CGM) has been widely applied in diabetes mellitus treatment. Nonetheless, its usage is witnessed more in other general metabolic health-related fields. CGM helps users monitor their blood glucose levels at all times and determine how their body reacts to particular foods, exercise, and stress.
It can also be helpful for women to learn more about blood sugar fluctuations because According to diabetic women. Fluctuations in hormones during the menstrual cycle, pregnancy, and postpartum, as well as during menopause, may influence the regulation of glucose levels. Consequently, through CGM, women can understand how these changes impact their bodies and make modifications to promote health.
Personalized Health Solutions Impact
Personalized health solutions such as Hello Inside are changing the face of health and wellness. These technologies enable people to take control of their health by presenting real-time data and timely recommendations that were not achievable otherwise.
For women, this is particularly significant. Conventional medicine does not recognize or adequately address women’s metabolic differences, leaving women underserved in terms of care. Inside entirely focuses on women’s health, which is why Hello Inside seeks to address these gaps with a solution that fits the need.
Future Prospects
The additional funding will help Hello Inside grow further and improve its services and offerings. The company also plans to continue to build features and extend integration that will deliver even higher value. This involves building on its catalog of customized recommendations and adding other health parameters.
Hello Inside also aims to expand its promotion campaigns to consist of more individuals, particularly females, with an emphasis on metabolic health issues. By raising awareness about CGM technology and using individual health data to provide more meaningful insights the company would like to help more people regain control over their health.
Conclusion
As the health technology market develops, Hello Inside stands out as unique and dedicated to the women’s health startup. Thus, the successful acquisition of €1.65 million in funding is just the start of what’s likely to be a fascinating relationship to improved women’s health.
